KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Amortization - Intangibles: 2019-2024

Historic Amortization - Intangibles for Pacira BioSciences (PCRX) over the last 6 years, with Dec 2024 value amounting to $57.3 million.

  • Pacira BioSciences' Amortization - Intangibles changed negligibly% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.3 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $57.3 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Amortization - Intangibles is $57.3 million, which was down 0.00% from $57.3 million recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Amortization - Intangibles peaked at $57.3 million during FY2023, and registered a low of $7.9 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Amortization - Intangibles value was $57.3 million (recorded in 2024), while the average stood at $57.3 million.
  • Data for Pacira BioSciences' Amortization - Intangibles shows a peak YoY spiked of 322.70% (in 2022) over the last 5 years.
  • Pacira BioSciences' Amortization - Intangibles (Yearly) stood at $7.9 million in 2020, then surged by 72.30% to $13.6 million in 2021, then soared by 322.70% to $57.3 million in 2022, then grew by 0.02% to $57.3 million in 2023, then remained steady at $57.3 million in 2024.